Viewing Study NCT06041568

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-06-04 @ 8:54 PM
Study NCT ID: NCT06041568
Status: TERMINATED
Last Update Posted: 2025-02-10
First Post: 2023-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Imvotamab in Severe Systemic Lupus Erythematosus
Sponsor: IGM Biosciences, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus Erythematosus View
None Lupus Erythematosus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lupus View
None SLE View
None Severe Lupus View
None Severe systemic lupus erythematosus View
None Systemic lupus erythematosus View